Framework conditions facilitating paediatric clinical research

Italian Journal of Pediatrics

Volumn 37, Issue 1, 2011, Pages

  Knellwolf, Anne Laure ^a   Bauzon, Stéphane ^b   Alberighi, Ornella Della Casa ^c   Lutsar, Irja ^d   Bácsy, Ernö ^e   Alfarez, Deborah ^f   Panei, Pietro ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d UNIVERSITY OF TARTU   (Estonia)

^e Medical Research Council of Hungary   (Hungary)

^f ERA NET Priority Medicines for Children Coordination   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

CLINICAL RESEARCH; DRUG INDUSTRY; HUMAN; INFORMED CONSENT; PATENT; PATIENT AUTONOMY; PROFESSIONAL STANDARD; RESEARCH ETHICS; REVIEW; RISK BENEFIT ANALYSIS; CHILD; CLINICAL TRIAL (TOPIC); ETHICS; EUROPE; LEGAL ASPECT; MEDICAL RESEARCH; PEDIATRICS;

BIOMEDICAL RESEARCH; CHILD; CLINICAL TRIALS AS TOPIC; EUROPE; HUMANS; PEDIATRICS;

EID: 79960950924     PISSN: 17208424     EISSN: 18247288     Source Type: Journal    
DOI: 10.1186/1824-7288-37-12     Document Type: Review

References (43)

1. European Commission Sixth Framework Programme FP6 Project no. 036266. Coordination of research on priority medicines for children. ERA-NET PRIOMEDCHILD, http://www.priomedchild.eu/
2. Regulation on medicinal products for paediatric use and amending Regulation. The European Parliament and the Council, http://eur-lex.europa.eu/ LexUriServ/site/en/consleg/2006/R/02006R1901-20070126-en.pdf
3. The European paediatric legislation: benefits and perspectives. Rocchi F, Paolucci P, Ceci A, Rossi P, Italian J Pediatr 2010 36 56
4. The EU's new paediatric medicines legislation: serving children's needs? Permanand G, Mossialos E, McKee M, Arch Dis Child 2007 92 808 811 (Pubitemid 47372537)
5. Consequences of Directives 2001/20/EC for investigator-initiated trials in the paediatric population-a filed report. Welzing L, Harnischmacher U, Weyersberg A, Roth B, Eur J Pediatr 2007 166 1169 1176 (Pubitemid 47476632)
6. A systematic review of safety and monitoring and drug toxicity in published controlled trials antiepileptic drugs in children over a 10 year period. Anderson M, Choonara I, Arch Dis Child 2010 95 731 738
7. Safety in pediatric clinical trials-a 7 year review. Sammons HM, Gray C, Hudson H, Cherrill J, Choonara I, Acta Paediatr 2008 97 474 477 (Pubitemid 351432298)
8. Developing paediatric medicines: identifying the needs and recognizing the challenges. Ernest TB, Elder DP, Martini LG, Roberts M, Ford JL, J Pharm Pharmacol 2007 59 1043 1055 (Pubitemid 47265351)
9. Paediatric drug development. Schachter AD, Ramoni MF, Nat Rev Drug Discov 2007 6 429 430 (Pubitemid 47064563)
10. Paediatric Clinical trials: redressing the imbalance. Schreiner MS, Nat Rev Drug Discov 2003 2 949 961 (Pubitemid 37540577)
11. Future of Pediatric Therapeutics: Reauthorization of BPCA and PREA. Ward RM, Kauffman R, Clin Pharmacol Ther 2007 81 477 479 (Pubitemid 46452311)
12. Stimulation programs for pediatric drug research-do children really benefit? Boots I, Sukhai RN, Klein RH, Holl RA, Wit JM, Cohen AF, Burggraaf J, Eur J Pediatr 2007 166 849 855 (Pubitemid 46988181)
13. Directive 2001/20/EC of the European Parliament and of the Council. http://ec.europa.eu/health/human-use/clinical-trials/index-en.htm
14. Code de la Santé Publique of the French Law, Protection des personnes en matière de santé Titre II: Recherches biomédicales, Chapitre VI: Dispositions pénales 2004 Article L. 1126-1
15. Legal Interpretation At The European Court Of Justice. Fennelly N, 20 Fordham Int'l L.J. 656 1997
16. Clinical trial in children. Caldwell PHY, Murphy SB, Butow PN, Craig JC, Lancet 2004 364 803 811
17. Parents' attitudes to children's participation in randomized controlled trials. Caldwell PHY, Butow PN, Craig JC, J Pediatr 2003 142 554 559 (Pubitemid 36623567)
18. From informed consent to shared consent: a developing process in paediatric oncology. Massimo LM, Wiley TJ, Casari EF, Lancet Oncol 2004 5 384 387 (Pubitemid 38684411)
19. Pediatricians' attitudes toward randomized controlled trials involving children. Caldwell PHY, Butow PN, Craig JC, J Pediatr 2002 141 798 803 (Pubitemid 35471641)
20. Guidelines for the ethical conduct of medical research involving children. Royal College of Paediatrics and Child Health: Ethics Advisory Committee. McIntosh N, Bates P, Brykczynska G, Dunstan G, Goldman A, Harvey D, Larcher V, McCrae D, McKinnon A, Patton M, Saunders J, Shelley P, Arch Dis Child 2000 82 177 182 (Pubitemid 30305718)
21. Ethical issues of clinical trials in children: a European perspective. Sammons H, Arch Dis Child 2009 94 474 477
22. The precautionary principle: protecting public health, the environment and the future of our children. 2004 http://www.euro.who.int/-data/assets/pdf- file/0003/91173/E83079.pdf
23. Clinical trials: the viewpoint of children with a chronic illness compared with healthy children. Cherrill J, Hudson H, Cocking C, Unsworth V, Franck L, Fakis A, McIntyre J, Choonara I, Arch Dis Child 2010 95 229 232
24. Informed consent for pediatric research: is it really possible? Kodish E, J Pediatr 2003 142 89 90 (Pubitemid 36232889)
25. European survey on the ethical and legal frameworks of clinical trials in paediatrics; results and perpectives. Altavilla A, Giaquinto C, Ceci A, J Int Bioéthique 2008 19 17 48 121-122
26. Ethical considerations for clinical trials on medicinal products with paediatric population. 2008 http://ec.europa.eu/health/files/eudralex/vol-10/ ethical-considerations-en.pdf
27. Assent in paediatric research: theoretical and practical considerations. Wendler DS, J Med Ethics 2006 32 229 234
28. Ethical principles and operational guidelines for good clinical practice in paediatric research. Recommendations of the ethics working group of Confederation of European Specialists in Paediatrics (CESP). Gill D, Eur J Pediatr 2004 163 53 57 (Pubitemid 38223385)
29. Additional Protocol to the Convention on Human Rights and Biomedicine, concerning Biomedical Research. Council of Europe, 2005 http://conventions.coe. int/treaty/en/treaties/html/195.htm
30. Children's and their parents' views on facing research risks for the benefit of others. Wendler D, Jenkins T, Arch Pediatr Adolesc Med 2008 162 9 14
31. Drug development for children: how adequate is the current European ethical guidance? Westra AE, Engberts DP, Sukhai RN, Wit JM, de Beaufort ID, Arch Dis Child 2010 95 3 6
32. Ethical issues in the daily medical care of children. Kurz R, Gill D, Mjones S, Eur J Pediatr 2006 165 83 86 (Pubitemid 43029755)
33. World Medical Association, Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects; 59th WMA General Assembly, Seoul, October 2008
34. Adaptation of the application of Good Clinical Practice depending on the features of research projects. Bertoye PH, Courcier-Duplantier S, Best N, the participants in Round Table N°2, Giens XXI, Therapie 2006 61 279 285
35. Effects of stimulant medication on growth rates 3 years in the MTA follow-up. Swanson JM, Elliott GR, Greenhill LL, Wigal T, Arnold LE, Vitiello B, Hechtman L, Epstein JN, Pelham WE, Abikoff HB, Newcorn JH, Molina BS, Hinshaw SP, Wells KC, Hoza B, Jensen PS, Gibbons RD, Hur K, Stehli A, Davies M, March JS, Conners CK, Caron M, Volkow ND, J Am Acad Child Adolesc Psychiatry 2007 46 1015 1027 (Pubitemid 47224817)
36. Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Committee on Drugs, American Academy on Pediatrics, Pediatrics 1995 95 286 294
37. Choice of Control group and related issues in clinical trials. ICH E10, http://www.ich.org/fileadmin/Public-Web-Site/ICH-products/Guidelines/Efficacy/ E10/Step4/E10-Guideline.pdf
38. British and Canadian views on the ethics paediatric clinical trials. Sammons HM, Malhotra J, Choonara I, Sitar DS, Matsui, Rieder MJ, Eur J Clin Pharm 2007 63 431 436 (Pubitemid 46569925)
39. The future of institutional review boards. Ghersi D, Campbell EG, Pentz R, Cox Macpherson C, Lancet Oncol 2004 5 325 329 (Pubitemid 38541587)
40. Paediatric clinical pharmacology at the beginning of a new era. Hoppu K, Eur J Clin Pharmacol 2008 64 201 205
41. Are research ethics committees behaving unethically? Committees are now being expected to do everything. Pierce E, BMJ 1997 314 676
42. Multicentre research ethics committees: has the cure been worse than the disease? Alberti K, BMJ 2000 320 1157 1158 (Pubitemid 30224260)
43. A central institutional review board for multi-institutional trials. Christian MC, Goldberg JL, Killen J, Abrams JS, McCabe MS, Mauer JK, Wittes RE, N Engl J Med 2002 346 1405 1408 (Pubitemid 34754617)